Status:
COMPLETED
Phospholipase A2 Producing Bacteria and Pre-Term Labor
Lead Sponsor:
CAMC Health System
Conditions:
Preterm Labor
Eligibility:
FEMALE
14-45 years
Brief Summary
The purpose of this study is to better understand (1) if phospholipase A2 producing microorganisms and cytokines (IL-1, IL-4, IL-6, IL-10, and IL-13) are associated with premature labor (2) if pregnan...
Eligibility Criteria
Inclusion
- Gestational age \<34 weeks
- Singleton gestation
- Urinalysis and urine culture collected via clean catch
- Age range 14 - 45
- Patient receiving prenatal care at CAMC Women's Medicine Center
Exclusion
- In labor or with uterine contractions
- Known fetal anomalies
- Cerclage
- Dark amniotic fluid suggestive of previous bleeding
- Multiple gestation
- Known unbalance chromosomal complement
- Pregnant patient with prior history of excisional cervical biopsy (either cold knife, loop electrosurgical excision procedure, or laser conization)
- Patient with mullerian anomaly
- Patient with 2 or more D\&E secondary to spontaneous or induced abortion
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00855543
Start Date
August 1 2009
End Date
December 1 2010
Last Update
July 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charleston Area Medical Center/West Virginia University
Charleston, West Virginia, United States, 25304